Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Post Intensive Care Unit Atrial Fibrillation

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Atrial fibrillation (AF) is a common heart rhythm disorder in the intensive care unit (ICU). It can be precipitated by multiple factors but it is unclear whether AF persists after discharge from the ICU, and long term. This study will investigate whether AF recurs up to one year after ICU discharge.

Who May Be Eligible (Plain English)

Who May Qualify: - Age \>18 years - New onset atrial fibrillation diagnosed in the ICU (12 lead ECG or documented episode of atrial fibrillation lasting at least 30 seconds) - Patient hospitalized in the ICU with at least one of the following two criteria: - orotracheal intubation for mechanical ventilation - AND/OR treatment with amines (vasopressors or inotropic agents) - Written willing to sign a consent form - Patient affiliated to a social security regime (or beneficiary thereof) Who Should NOT Join This Trial: - Documented history of atrial fibrillation - patients admitted to the ICU after cardiothoracic surgery - Patients with life expectancy \<12 months - Patients under legal or judicial protection - Patients with no social security coverage - Patients within the exclusion period of another clinical trial Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age \>18 years * New onset atrial fibrillation diagnosed in the ICU (12 lead ECG or documented episode of atrial fibrillation lasting at least 30 seconds) * Patient hospitalized in the ICU with at least one of the following two criteria: * orotracheal intubation for mechanical ventilation * AND/OR treatment with amines (vasopressors or inotropic agents) * Written informed consent * Patient affiliated to a social security regime (or beneficiary thereof) Exclusion Criteria: * Documented history of atrial fibrillation * patients admitted to the ICU after cardiothoracic surgery * Patients with life expectancy \<12 months * Patients under legal or judicial protection * Patients with no social security coverage * Patients within the exclusion period of another clinical trial

Treatments Being Tested

DEVICE

Implantable ECG holter device (Biomonitor3, Biotronik)

Subcutaneous implantation of ECG holder device to monitor ECG

Locations (1)

Centre Hospitalier Universitaire de Besancon
Besançon, France